274 related articles for article (PubMed ID: 19651773)
21. Aberrant cellular behavior of mutant torsinA implicates nuclear envelope dysfunction in DYT1 dystonia.
Gonzalez-Alegre P; Paulson HL
J Neurosci; 2004 Mar; 24(11):2593-601. PubMed ID: 15028751
[TBL] [Abstract][Full Text] [Related]
22. The early-onset torsion dystonia-associated protein, torsinA, displays molecular chaperone activity in vitro.
Burdette AJ; Churchill PF; Caldwell GA; Caldwell KA
Cell Stress Chaperones; 2010 Sep; 15(5):605-17. PubMed ID: 20169475
[TBL] [Abstract][Full Text] [Related]
23. Structures of TorsinA and its disease-mutant complexed with an activator reveal the molecular basis for primary dystonia.
Demircioglu FE; Sosa BA; Ingram J; Ploegh HL; Schwartz TU
Elife; 2016 Aug; 5():. PubMed ID: 27490483
[TBL] [Abstract][Full Text] [Related]
24. The nuclear envelope localization of DYT1 dystonia torsinA-ΔE requires the SUN1 LINC complex component.
Jungwirth MT; Kumar D; Jeong DY; Goodchild RE
BMC Cell Biol; 2011 May; 12():24. PubMed ID: 21627841
[TBL] [Abstract][Full Text] [Related]
25. TorsinA: movement at many levels.
Breakefield XO; Kamm C; Hanson PI
Neuron; 2001 Jul; 31(1):9-12. PubMed ID: 11498045
[TBL] [Abstract][Full Text] [Related]
26. Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells.
Misbahuddin A; Placzek MR; Taanman JW; Gschmeissner S; Schiavo G; Cooper JM; Warner TT
Mov Disord; 2005 Apr; 20(4):432-440. PubMed ID: 15593317
[TBL] [Abstract][Full Text] [Related]
27. Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1A.
Hettich J; Ryan SD; de Souza ON; Saraiva Macedo Timmers LF; Tsai S; Atai NA; da Hora CC; Zhang X; Kothary R; Snapp E; Ericsson M; Grundmann K; Breakefield XO; Nery FC
Hum Mutat; 2014 Sep; 35(9):1101-13. PubMed ID: 24930953
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the direct pathway in Dyt1 ΔGAG heterozygous knock-in mice and dopamine receptor 1-expressing-cell-specific Dyt1 conditional knockout mice.
Yokoi F; Chen HX; Oleas J; Dang MT; Xing H; Dexter KM; Li Y
Behav Brain Res; 2021 Aug; 411():113381. PubMed ID: 34038798
[TBL] [Abstract][Full Text] [Related]
29. Exploring the influence of torsinA expression on protein quality control.
Gordon KL; Glenn KA; Gonzalez-Alegre P
Neurochem Res; 2011 Mar; 36(3):452-9. PubMed ID: 21161590
[TBL] [Abstract][Full Text] [Related]
30. Perinuclear biogenesis of mutant torsin-A inclusions in cultured cells infected with tetracycline-regulated herpes simplex virus type 1 amplicon vectors.
Bragg DC; Camp SM; Kaufman CA; Wilbur JD; Boston H; Schuback DE; Hanson PI; Sena-Esteves M; Breakefield XO
Neuroscience; 2004; 125(3):651-61. PubMed ID: 15099679
[TBL] [Abstract][Full Text] [Related]
31. TorsinA in the nuclear envelope.
Naismith TV; Heuser JE; Breakefield XO; Hanson PI
Proc Natl Acad Sci U S A; 2004 May; 101(20):7612-7. PubMed ID: 15136718
[TBL] [Abstract][Full Text] [Related]
32. Mutant torsinA, responsible for early-onset torsion dystonia, forms membrane inclusions in cultured neural cells.
Hewett J; Gonzalez-Agosti C; Slater D; Ziefer P; Li S; Bergeron D; Jacoby DJ; Ozelius LJ; Ramesh V; Breakefield XO
Hum Mol Genet; 2000 May; 9(9):1403-13. PubMed ID: 10814722
[TBL] [Abstract][Full Text] [Related]
33. Early-onset torsion dystonia: a novel high-throughput yeast genetic screen for factors modifying protein levels of torsinAΔE.
Zacchi LF; Dittmar JC; Mihalevic MJ; Shewan AM; Schulz BL; Brodsky JL; Bernstein KA
Dis Model Mech; 2017 Sep; 10(9):1129-1140. PubMed ID: 28768697
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of N-linked glycosylation prevents inclusion formation by the dystonia-related mutant form of torsinA.
Bragg DC; Kaufman CA; Kock N; Breakefield XO
Mol Cell Neurosci; 2004 Dec; 27(4):417-26. PubMed ID: 15555920
[TBL] [Abstract][Full Text] [Related]
35. Generation and characterization of Dyt1 DeltaGAG knock-in mouse as a model for early-onset dystonia.
Dang MT; Yokoi F; McNaught KS; Jengelley TA; Jackson T; Li J; Li Y
Exp Neurol; 2005 Dec; 196(2):452-63. PubMed ID: 16242683
[TBL] [Abstract][Full Text] [Related]
36. Dynamic functional assembly of the Torsin AAA+ ATPase and its modulation by LAP1.
Chase AR; Laudermilch E; Wang J; Shigematsu H; Yokoyama T; Schlieker C
Mol Biol Cell; 2017 Oct; 28(21):2765-2772. PubMed ID: 28814508
[TBL] [Abstract][Full Text] [Related]
37. Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells.
Hewett JW; Tannous B; Niland BP; Nery FC; Zeng J; Li Y; Breakefield XO
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7271-6. PubMed ID: 17428918
[TBL] [Abstract][Full Text] [Related]
38. TorsinA participates in endoplasmic reticulum-associated degradation.
Nery FC; Armata IA; Farley JE; Cho JA; Yaqub U; Chen P; da Hora CC; Wang Q; Tagaya M; Klein C; Tannous B; Caldwell KA; Caldwell GA; Lencer WI; Ye Y; Breakefield XO
Nat Commun; 2011 Jul; 2():393. PubMed ID: 21750546
[TBL] [Abstract][Full Text] [Related]
39. The Role of Torsin AAA+ Proteins in Preserving Nuclear Envelope Integrity and Safeguarding Against Disease.
Rampello AJ; Prophet SM; Schlieker C
Biomolecules; 2020 Mar; 10(3):. PubMed ID: 32204310
[TBL] [Abstract][Full Text] [Related]
40. Genetic mutations strengthen functional association of LAP1 with DYT1 dystonia and muscular dystrophy.
Rebelo S; da Cruz E Silva EF; da Cruz E Silva OA
Mutat Res Rev Mutat Res; 2015; 766():42-7. PubMed ID: 26596547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
